By Professor Colleen Loo

Journal articles

Massaneda-Tuneu C; Martin D; Glozier N; Bayes A; Cao TV; Thornton N; Brettell L; Antoniou S; Barreiros AR; Flynn M; Dong V; Lun E; Karunaratne N; Moreno D; Ellis J; Samuels O; Fowler I; Bull M; Mitchell PB; Loo CK, 2026, 'Real-world clinical data on the long-term effectiveness and safety of generic racemic ketamine treatment', Journal of Affective Disorders, 392, http://dx.doi.org/10.1016/j.jad.2025.120192

Chatterton ML; Perez JK; Thai T; Faller J; Loo CK; Glozier N; Barton D; Baune BT; Mills NT; Fitzgerald PB; Glue P; Sarma S; Hadzi-Pavlovic D; Dong V; Martin D; Mitchell PB; Berk M; Carter G; Hackett M; Hood S; Somogyi AA; Rodgers A; Mihalopoulos C, 2025, 'Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial – The KADS study', Journal of Affective Disorders, 387, http://dx.doi.org/10.1016/j.jad.2025.119502

Nejati V; Vaziri Z; Antal A; Antonenko D; Behroozmand R; Bestmann S; Brunelin J; Brunoni AR; Carvalho S; Davis NJ; Enticott PG; Fallgatter AJ; Ferrucci R; Fitzgerald PB; Hamada M; Hamilton RH; Hoy KE; Jaberzadeh S; Jamil A; Cohen Kadosh R; Krekelberg B; Laureys S; Romero Lauro LJ; Loo CK; Martin D; Martinotti G; Mondino M; Oliviero A; Pellicciari MC; Plewnia C; Pobric G; De Raedt R; Razza LB; Rocchi L; Salehinejad MA; Khorrami AS; Schecklmann M; Siebner HR; Taylor SF; Vanderhasselt M-A; Vanneste S; Vicario CM; Woods AJ; Ziemann U; Nitsche MA, 2025, 'Report Approval for Transcranial Electrical Stimulation (RATES): expert recommendation based on a Delphi consensus study', NATURE PROTOCOLS, http://dx.doi.org/10.1038/s41596-025-01259-0

Mills NT; Nikolin S; Glozier N; Barton D; Baune BT; Fitzgerald PB; Glue P; Sarma S; Rodgers A; Hadzi-Pavlovic D; Alonzo A; Dong V; Martin D; Mitchell PB; Berk M; Carter G; Hackett ML; Somogyi AA; Mihalopoulos C; Chatterton ML; Hood S; Loo CK, 2025, 'Effect of ketamine on anxiety: Findings from the Ketamine for Adult Depression Study', British Journal of Psychiatry, 227, pp. 601 - 607, http://dx.doi.org/10.1192/bjp.2024.250

Massaneda-Tuneu C; Loo C; Martin D, 2025, 'Patients' Cognitive Potential Is Associated with Cognitive Performance after an Acute Course of Electroconvulsive Therapy', Journal of ECT, 41, pp. 206 - 211, http://dx.doi.org/10.1097/YCT.0000000000001057

Hussain S; Gale C; Sarma S; Smith J; Bayes A; Loo C, 2025, 'Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the use of ketamine in psychiatric practice', Australian and New Zealand Journal of Psychiatry, 59, pp. 576 - 587, http://dx.doi.org/10.1177/00048674251333577

Lundin RM; Leung M; Loo C; Doane M, 2025, 'Potential Pitfalls from Long-Acting Injectable Buprenorphine during ECT Treatment', Journal of ECT, 41, pp. e21 - e22, http://dx.doi.org/10.1097/YCT.0000000000001076

Carroll A; Rae CD; Martin D; Dokos S; Loo C, 2025, 'The Effect of Cranial Sutures Should Be Considered in Transcranial Electrical Stimulation', Journal of ECT, 41, pp. 111 - 118, http://dx.doi.org/10.1097/YCT.0000000000001079

Nikolin S; Moffa A; Martin D; Loo C; Boonstra T, 2025, 'Assessing Neuromodulation Effects of Theta Burst Stimulation to the Prefrontal Cortex Using Transcranial Magnetic Stimulation Electroencephalography (TMS-EEG)', European Journal of Neuroscience, 61, pp. e70121, http://dx.doi.org/10.1111/ejn.70121

Loo C; Alonzo A; Barton D; Berk M; Chatterton ML; Dong V; Gálvez V; Mills NT; Mitchell PB; Sarma S; Somogyi AA; Rodgers A, 2025, 'Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): Randomised double-blind active-controlled trial: Commentary, author response', British Journal of Psychiatry, 226, pp. 317 - 318, http://dx.doi.org/10.1192/bjp.2024.176

Lundin RM; Kannangara S; Jenkins M; Carroll T; Wakefield K; Patrick C; Abdar M; Khosravi A; Loo C; Berk M, 2025, 'It is time to reassess reporting of electroconvulsive therapy data in New Zealand: A 17-year retrospective analysis of treatment data from Waikato', Australian and New Zealand Journal of Psychiatry, 59, pp. 423 - 432, http://dx.doi.org/10.1177/00048674251324795

Xu X; Nikolin S; Moffa AH; Xu M; Cao TV; Loo CK; Martin DM, 2025, 'Effects of repetitive transcranial magnetic stimulation combined with cognitive training for improving response inhibition: A proof-of-concept, single-blind randomised controlled study', Behavioural Brain Research, 480, http://dx.doi.org/10.1016/j.bbr.2024.115372

Bayes A; Cao TV; Barreiros AR; Massaneda-Tuneu C; Dong V; Thornton N; Glozier N; Beesley L; Moreno D; Gálvez-Ortiz V; Short B; Martin D; Loo C, 2025, 'Safety outcomes of ketamine for treatment-resistant depression in clinical settings and development of the ketamine side effect tool-revised (KSET-R)', Psychiatry Research, 344, http://dx.doi.org/10.1016/j.psychres.2024.116334

Martin DM; Alduraywish A; Bakir AA; Dokos, Phd S; Bakouri M; Bai S; Sackeim HA; Loo CK, 2025, 'A Computational Modeling Study of Focal Electrically Administered Seizure Therapy and Frontoparietal Electroconvulsive Therapy', Journal of ECT, http://dx.doi.org/10.1097/YCT.0000000000001135

Carroll A; Rae C; Martin D; Dokos S; Loo C, 2025, 'Cranial Sutures Alter Computational Models of Transcranial Electrical Stimulation', Journal of ECT, http://dx.doi.org/10.1097/YCT.0000000000001154

Massaneda-Tuneu C; Loo C; Martin D, 2025, 'Revitalizing Lost Memories: Long-Term Swift Learning and Improvement Post Electroconvulsive Therapy: A Case Report', Journal of ECT, http://dx.doi.org/10.1097/YCT.0000000000001116

Barreiros AR; Massaneda-Tuneu C; Waite S; Sarma S; Branjerdporn G; Zeng C; Dong V; Loo C; Martin DM, 2025, 'The effects of treatment, clinical and demographic factors on recovery of orientation after ECT: A care network study', Journal of Affective Disorders, 368, pp. 337 - 342, http://dx.doi.org/10.1016/j.jad.2024.09.097

Aoki N; Tajika A; Suwa T; Kawashima H; Yasuda K; Shimizu T; Uchinuma N; Tominaga H; Tan X-W; Koh A-H; Tor P-C; Nicolin S; Martin D; Kinoshita T; Kato M; Loo C; Furukawa T-A; Kinoshita Y, 2025, 'How long and how often does ECT for schizophrenia relapse? A systematic review & meta-analysis', Brain Stimulation, 18, pp. 503 - 503, http://dx.doi.org/10.1016/j.brs.2024.12.842

Lundin R; Abdar M; Khosravi A; Loo C; Berk M, 2025, 'Machine learning in electroconvulsive therapy', Brain Stimulation, 18, pp. 345 - 345, http://dx.doi.org/10.1016/j.brs.2024.12.395

Huang H; Moffa AH; Martin D; Loo CK; Nikolin S, 2025, 'Optimising transcranial direct current stimulation current intensity for working memory enhancement in healthy individuals: A single-case experimental design', Brain Stimulation, 18, pp. 554 - 554, http://dx.doi.org/10.1016/j.brs.2024.12.987

Tuneu CM; Martin D; Loo C, 2025, 'Patients' educational level and lifetime occupational attainment are associated with cognitive performance after an acute course of Electroconvulsive Therapy', Brain Stimulation, 18, pp. 458 - 458, http://dx.doi.org/10.1016/j.brs.2024.12.713

Sarma S; McCosker L; Xu X; Nikolin S; Loo C; Martin D, 2025, 'Repetitive transcranial magnetic stimulation (rTMS) of the dorsomedial prefrontal cortex (DMPFC): A systematic review and meta-analysis of symptom outcomes in psychiatric disorders', Brain Stimulation, 18, pp. 592 - 592, http://dx.doi.org/10.1016/j.brs.2024.12.1094

Loo C; Barreiros AR; Martin D; Dong V; George MS; Mccall WV; Sarma S; Hopwood M; Weiss A; Bull M; Tuneu CM; Alonzo A; Hadzi-Pavlovic D; Rodgers A; Sahlem GL; Harvey AJ; Haldane K; Brettell L; Fitzgerald PB; Dokos S; Sackeim H, 2024, 'A Randomized Controlled Trial of Ultrabrief Right Unilateral ECT With Frontoparietal Versus Temporoparietal Electrode Placement for Severe Depression - The RAFT ECT Trial', Journal of ECT, 40, pp. 229 - 231, http://dx.doi.org/10.1097/YCT.0000000000001018

Ahmad Bakir A; Martin DM; Alduraywish A; Dokos S; Loo CK, 2024, 'Electroconvulsive Therapy With Brain Cyst A Simulation Study', Journal of ECT, 40, pp. 277 - 285, http://dx.doi.org/10.1097/YCT.0000000000001045

Lundin RM; Falcao VP; Kannangara S; Eakin CW; Abdar M; O'Neill J; Khosravi A; Eyre H; Nahavandi S; Loo C; Berk M, 2024, 'Machine Learning in Electroconvulsive Therapy A Systematic Review', Journal of ECT, 40, pp. 245 - 253, http://dx.doi.org/10.1097/YCT.0000000000001009

Xu M; Nikolin S; Moffa AM; Xu XM; Su Y; Li R; Chan HF; Loo CK; Martin DM; de Matos Moffa AH, 2024, 'Prolonged intermittent theta burst stimulation targeting the left prefrontal cortex and cerebellum does not affect executive functions in healthy individuals', Scientific Reports, 14, pp. 11847, http://dx.doi.org/10.1038/s41598-024-61404-9

Tor PC; Barreiros AR; Cao TV; Dong V; Brettell L; Tuneu CM; Galvez V; Waite S; Sarma S; Branjerdporn G; Chatterton ML; Mohan T; Hussain S; Martin D; Loo C, 2024, 'Why You Should Collect Routine Clinical Data for ECT: A Singapore Story from the CARE Network', Journal of ECT, 40, pp. 225 - 228, http://dx.doi.org/10.1097/YCT.0000000000001012

Aoki N; Tajika A; Suwa T; Kawashima H; Yasuda K; Shimizu T; Uchinuma N; Tominaga H; Tan XW; Koh AHK; Tor PC; Nikolin S; Martin D; Kato M; Loo C; Kinoshita T; Furukawa TA; Takekita Y, 2024, 'Relapse Following Electroconvulsive Therapy for Schizophrenia: A Systematic Review and Meta-analysis', SCHIZOPHRENIA BULLETIN, http://dx.doi.org/10.1093/schbul/sbae169

Carroll A; Bayes A; Montebello M; Brett J; Arunogiri S; Saunders JB; Loo CK, 2024, 'Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand', Australian and New Zealand Journal of Psychiatry, 58, pp. 831 - 838, http://dx.doi.org/10.1177/00048674241242315

Dong V; Brettell L; Massaneda-Tuneu C; Rita Barreiros A; Vinh Cao T; Kelly C; Zeng Y; Aoki N; Tor PC; Bayes A; Branjerdporn G; Sarma S; Kwan E; Waite S; Mohan T; Hussain S; Gálvez V; Weiss A; Bull M; Lou Chatterton M; Mihalopoulos C; Glozier N; Hadzi-Pavlovic D; Hopwood M; Mitchell P; Power B; Sara G; Wells K; Loo C; Martin D; Barreiros AR, 2024, 'Facilitating routine data collection to improve clinical quality and research in Interventional Psychiatry: The CARE Network', Australian and New Zealand Journal of Psychiatry, 58, pp. 738 - 741, http://dx.doi.org/10.1177/00048674241266057

Chen T; Loo C; Salvador-Carulla L; Jorm LR; Srasuebkul P; Sara G; Quiroz JC; Gallego B, 2024, 'Factors associated with electroconvulsive therapy treatment for adults with serious psychiatric conditions in Australia', Australian and New Zealand Journal of Psychiatry, 58, pp. 809 - 820, http://dx.doi.org/10.1177/00048674241266067

Sarma S; Zeng Y; Barreiros AR; Dong V; Massaneda-Tuneu C; Cao TV; Waite S; McCosker LK; Branjerdporn G; Loo CK; Martin DM, 2024, 'Clinical Outcomes of Electroconvulsive Therapy (ECT) for Depression in Older Old People Relative to Other Age Groups Across the Adult Life Span: A CARE Network Study', International Journal of Geriatric Psychiatry, 39, http://dx.doi.org/10.1002/gps.6133

Loo C; Glozier N; Barton D; Baune BT; Mills NT; Fitzgerald P; Glue P; Sarma S; Galvez-Ortiz V; Hadzi-Pavlovic D; Alonzo A; Dong V; Martin D; Nikolin S; Mitchell PB; Berk M; Carter G; Hackett M; Leyden J; Hood S; Somogyi AA; Lapidus K; Stratton E; Gainsford K; Garg D; Thornton NLR; Fourrier C; Richardson K; Rozakis D; Scaria A; Mihalopoulos C; Chatterton ML; McDonald WM; Boyce P; Holtzheimer PE; Kozel FA; Riva-Posse P; Rodgers A, 2024, 'Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM', British Journal of Psychiatry the Journal of Mental Science, 225, pp. 349, http://dx.doi.org/10.1192/bjp.2024.189

Hussain S; Chamoli S; Fitzgerald P; Gandhi A; Gill S; Sarma S; Loo C, 2024, 'Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation', Australian and New Zealand Journal of Psychiatry, 58, pp. 641 - 655, http://dx.doi.org/10.1177/00048674241249846

Glue P; Loo C; Fam J; Lane HY; Young AH; Surman P; Glozier N; Fitzgerald P; Liu D; Sharma S; Grunfeld J; Barton D; Hopwood M; Miles W; Williams M; Carson S; Tor PC; Chen CH; Huang YJ, 2024, 'Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial', Nature Medicine, 30, pp. 2004 - 2009, http://dx.doi.org/10.1038/s41591-024-03063-x

Martin DM; Harvey AJ; Baune B; Berk M; Carter GL; Dong V; Glozier N; Glue P; Hood S; Hadzi-Pavlovic D; Hackett M; Mills N; Sarma S; Somogyi A; Rodgers A; Loo CK, 2024, 'Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)', Journal of Affective Disorders, 352, pp. 163 - 170, http://dx.doi.org/10.1016/j.jad.2024.02.052

Martin DM; Su Y; Chan HF; Dielenberg V; Chow E; Xu M; Wang A; Nikolin S; Moffa AH; Loo CK, 2024, 'Individualised Transcranial Magnetic Stimulation Targeting of the Left Dorsolateral Prefrontal Cortex for Enhancing Cognition: A Randomised Controlled Trial', Brain Sciences, 14, pp. 299, http://dx.doi.org/10.3390/brainsci14040299

Xu M; Nikolin S; Samaratunga N; Chow EJH; Loo CK; Martin DM, 2024, 'Cognitive Effects Following Offline High-Frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) in Healthy Populations: A Systematic Review and Meta-Analysis', Neuropsychology Review, 34, pp. 250 - 276, http://dx.doi.org/10.1007/s11065-023-09580-9

Purushothaman S; Simpson B; Hussain S; Loo CK; Gill S; Chamoli S; Weiss A; Sarma S; Fitzgerald PB; Fasnacht M; Gandhi A, 2024, 'Electroconvulsive Therapy Credentialing for Psychiatrists-Review of Required Standards Across States and Territories in Australia', Journal of ECT, 40, pp. 10 - 14, http://dx.doi.org/10.1097/YCT.0000000000000955

Solaja I; Haldane K; Mason N; Weiss B; Xu X; Xu M; Nikolin S; Jayasena T; Millard M; Brett J; Bayes A; Loo CK; Martin DM, 2024, 'Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personality', Neuroscience and Biobehavioral Reviews, 158, http://dx.doi.org/10.1016/j.neubiorev.2024.105570

Rodgers A; Bahceci D; Davey CG; Chatterton ML; Glozier N; Hopwood M; Loo C, 2024, 'Ensuring the affordable becomes accessible–lessons from ketamine, a new treatment for severe depression', Australian and New Zealand Journal of Psychiatry, 58, pp. 109 - 116, http://dx.doi.org/10.1177/00048674231203898

Hohoff C; Van Assche E; Statz V; Wissing SM; Schwarte K; Berk M; Carter GL; Dong V; Glozier N; Glue P; Hackett ML; Hadzi-Pavlovic D; Harvey AJ; Hood S; Martin DM; Mills NT; Sarma S; Somogyi A; Rodgers A; Loo CK; Baune BT, 2024, 'Association of blood-based inflammatory proteins with MADRS change after repeated subcutaneous ketamine injections in treatment-resistant depressive patients', Neuroscience Applied, 3, pp. 104280 - 104280, http://dx.doi.org/10.1016/j.nsa.2024.104280

Van Assche E; Hohoff C; Wissing SM; Statz V; Berk M; Carter GL; Dong V; Glozier N; Glue P; Hackett M; Hadzi-Pavlovic D; Harvey AJ; Hood S; Martin DM; Mills NT; Sarma S; Somogyi AA; Rodgers A; Loo CK; Baune BT, 2024, 'Expecting the unexpected: DNA methylation changes after a single dose of ketamine?', Neuroscience Applied, 3, pp. 104353 - 104353, http://dx.doi.org/10.1016/j.nsa.2024.104353

Wissing SM; Hohoff C; Van Assche E; Statz V; Lange P; Sandmann S; Berk M; Carter GL; Dong V; Glozier N; Glue P; Hackett ML; Hadzi-Pavlovic D; Harvey AJ; Hood S; Martin DM; Mills NT; Sarma S; Somogyi A; Rodgers A; Loo CK; Baune BT, 2024, 'Longitudinal analysis of differentially expressed genes in pharmacologically treated patients with treatment-resistant depression', Neuroscience Applied, 3, pp. 104287 - 104287, http://dx.doi.org/10.1016/j.nsa.2024.104287

Statz V; Hohoff C; Van Assche E; Wissing SM; Berk M; Carter GL; Dong V; Glozier N; Glue P; Hackett ML; Hadzi-Pavlovic D; Harvey AJ; Hood S; Martin DM; Mills NT; Sarma S; Somogyi A; Rodgers A; Loo CK; Baune BT, 2024, 'Pharmacogenomic interactions of ketamine and BDNF genetic variants in patients with treatment-resistant depression', Neuroscience Applied, 3, pp. 105043 - 105043, http://dx.doi.org/10.1016/j.nsa.2024.105043

Loo C; Glozier N; Barton D; Baune BT; Mills NT; Fitzgerald P; Glue P; Sarma S; Galvez-Ortiz V; Hadzi-Pavlovic D; Alonzo A; Dong V; Martin D; Nikolin S; Mitchell PB; Berk M; Carter G; Hackett M; Leyden J; Hood S; Somogyi AA; Lapidus K; Stratton E; Gainsford K; Garg D; Thornton NLR; Fourrier C; Richardson K; Rozakis D; Scaria A; Mihalopoulos C; Chatterton ML; Mcdonald WM; Boyce P; Holtzheimer PE; Kozel FA; Riva-Posse P; Rodgers A, 2023, 'Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial', British Journal of Psychiatry, 223, pp. 533 - 541, http://dx.doi.org/10.1192/bjp.2023.79

Xu X; Xu M; Su Y; Cao TV; Nikolin S; Moffa A; Loo C; Martin D, 2023, 'Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Combined with Psychological Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Brain Sciences, 13, pp. 1665, http://dx.doi.org/10.3390/brainsci13121665

Harvey AJ; Madden S; Rodgers A; Bull M; Chatterton ML; Hadzi-Pavlovic D; Loo CK; Martin DM, 2023, 'Randomised controlled trial of neurostimulation for symptoms of anorexia nervosa (TRENA study): study protocol', Journal of Eating Disorders, 11, pp. 218, http://dx.doi.org/10.1186/s40337-023-00940-7

Schwartz OS; Amminger P; Baune BT; Bedi G; Berk M; Cotton SM; Daglas-Georgiou R; Glozier N; Harrison B; Hermens DF; Jennings E; Lagopoulos J; Loo C; Mallawaarachchi S; Martin D; Phelan B; Read N; Rodgers A; Schmaal L; Somogyi AA; Thurston L; Weller A; Davey CG, 2023, 'The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder', Trials, 24, pp. 686, http://dx.doi.org/10.1186/s13063-023-07631-3

Lee W; Sheehan C; Chye R; Chang S; Bayes A; Loo C; Draper B; Agar MR; Currow DC, 2023, 'Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study', Plos One, 18, pp. e0290876, http://dx.doi.org/10.1371/journal.pone.0290876

Back to profile page